Shanghai RAAS Blood Products Co., Ltd.

Shenzhen Stock Exchange 002252.SZ

Shanghai RAAS Blood Products Co., Ltd. Net Income for the year ending December 31, 2023: USD 250.64 M

Shanghai RAAS Blood Products Co., Ltd. Net Income is USD 250.64 M for the year ending December 31, 2023, a -8.00% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Shanghai RAAS Blood Products Co., Ltd. Net Income for the year ending December 31, 2022 was USD 272.44 M, a 33.73% change year over year.
  • Shanghai RAAS Blood Products Co., Ltd. Net Income for the year ending December 31, 2021 was USD 203.73 M, a 0.46% change year over year.
  • Shanghai RAAS Blood Products Co., Ltd. Net Income for the year ending December 31, 2020 was USD 202.79 M, a 132.31% change year over year.
  • Shanghai RAAS Blood Products Co., Ltd. Net Income for the year ending December 31, 2019 was USD 87.29 M, a 139.41% change year over year.
Key data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Net Income Margin
Market news
Loading...
Shenzhen Stock Exchange: 002252.SZ

Shanghai RAAS Blood Products Co., Ltd.

CEO Mr. Jun Xu
IPO Date June 12, 2008
Location China
Headquarters No. 2009, Wangyuan Road
Employees 3,254
Sector Health Care
Industries
Description

Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. It also provides testing services for blood products, vaccines, diagnostic reagents, and testing equipment. The company also exports its products to Southeast Asia and Latin America. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.

Similar companies

000538.SZ

Yunnan Baiyao Group Co.,Ltd

USD 7.83

2.23%

000963.SZ

Huadong Medicine Co., Ltd

USD 4.53

2.64%

002304.SZ

Jiangsu Yanghe Brewery Joint-Stock Co., Ltd.

USD 10.96

2.23%

002236.SZ

Zhejiang Dahua Technology Co., Ltd.

USD 2.06

3.72%

002007.SZ

Hualan Biological Engineering Inc.

USD 2.17

2.25%

StockViz Staff

January 15, 2025

Any question? Send us an email